|
Jan 3
|
Ultragenyx Announces Completion of Enrollment in Global Phase 1/2 Trial of GTX-102 in Pediatric Patients with Angelman Syndrome
|
|
Jan 2
|
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 27
|
13 Most Promising Future Stocks To Buy According To Hedge Funds
|
|
Dec 21
|
Ultragenyx to Pay $6 Million to Settle Alleged False Medicare, Medicaid Claims
|
|
Dec 21
|
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Dec 18
|
Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)
|
|
Sep 7
|
Is Ultragenyx Pharmaceutical (RARE) Too Good to Be True? A Comprehensive Analysis of a ...
|
|
Aug 11
|
Henrietta Lacks' estate sues Ultragenyx over Mass.-made gene therapies
|
|
Aug 10
|
Henrietta Lacks' family sues Ultragenyx over use of HeLa cell line
|
|
Aug 8
|
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares Could Be 41% Below Their Intrinsic Value Estimate
|
|
Aug 8
|
15 Worst Performing Biotech Stocks in 2023
|